Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

EXOSC5 Antikörper (AA 1-235) (Biotin)

EXOSC5 Reaktivität: Human ELISA Wirt: Kaninchen Polyclonal Biotin
Produktnummer ABIN7152294
  • Target Alle EXOSC5 Antikörper anzeigen
    EXOSC5 (Exosome Component 5 (EXOSC5))
    Bindungsspezifität
    • 15
    • 8
    • 2
    • 1
    • 1
    • 1
    AA 1-235
    Reaktivität
    • 18
    • 16
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Human
    Wirt
    • 26
    • 5
    Kaninchen
    Klonalität
    • 28
    • 3
    Polyklonal
    Konjugat
    • 14
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser EXOSC5 Antikörper ist konjugiert mit Biotin
    Applikation
    • 13
    • 13
    • 11
    • 11
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    ELISA
    Kreuzreaktivität
    Human
    Aufreinigung
    >95%, Protein G purified
    Immunogen
    Recombinant Human Exosome complex component RRP46 protein (1-235AA)
    Isotyp
    IgG
    Top Product
    Discover our top product EXOSC5 Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    EXOSC5 (Exosome Component 5 (EXOSC5))
    Andere Bezeichnung
    EXOSC5 (EXOSC5 Produkte)
    Synonyme
    si:ch211-194n6.2 antikoerper, zgc:153707 antikoerper, EXOSC5 antikoerper, RRP41B antikoerper, RRP46 antikoerper, Rrp46p antikoerper, hRrp46p antikoerper, p12B antikoerper, D7Wsu180e antikoerper, exosome component 5 antikoerper, exosc5 antikoerper, EXOSC5 antikoerper, Exosc5 antikoerper
    Hintergrund

    Background: Non-catalytic component of the RNA exosome complex which has 3\'->5\' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding \'pervasive\' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3\' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes.

    Aliases: Chronic myelogenous leukemia tumor antigen 28 antibody, CML28 antibody, EXOS5_HUMAN antibody, EXOSC 5 antibody, Exosc5 antibody, Exosome complex component rrp46 antibody, exosome complex exonuclease RRP46 antibody, Exosome component 5 antibody, exosome component Rrp46 antibody, hRrp46p antibody, p12B antibody, Ribosomal RNA processing protein 46 antibody, Ribosomal RNA processing protein 46, S. cerevisiae, homolog of antibody, Ribosomal RNA-processing protein 46 antibody, RRP41B antibody, RRP46 antibody, Rrp46p antibody

    UniProt
    Q9NQT4
    Pathways
    SARS-CoV-2 Protein Interaktom
Sie sind hier: